These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28889377)

  • 21. Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression.
    Olkhov-Mitsel E; Hodgson A; Liu SK; Vesprini D; Xu B; Downes MR
    J Clin Pathol; 2022 Nov; 75(11):766-771. PubMed ID: 34103388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
    Lindgren D; Frigyesi A; Gudjonsson S; Sjödahl G; Hallden C; Chebil G; Veerla S; Ryden T; Månsson W; Liedberg F; Höglund M
    Cancer Res; 2010 May; 70(9):3463-72. PubMed ID: 20406976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma.
    Marzouka NA; Eriksson P; Bernardo C; Hurst CD; Knowles MA; Sjödahl G; Liedberg F; Höglund M
    J Mol Diagn; 2022 Sep; 24(9):992-1008. PubMed ID: 35853574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder cancer: novel molecular characteristics, diagnostic, and therapeutic implications.
    Kompier LC; van Tilborg AA; Zwarthoff EC
    Urol Oncol; 2010; 28(1):91-6. PubMed ID: 20123356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a molecular pathologic classification of urothelial carcinoma.
    Sjödahl G; Lövgren K; Lauss M; Patschan O; Gudjonsson S; Chebil G; Aine M; Eriksson P; Månsson W; Lindgren D; Fernö M; Liedberg F; Höglund M
    Am J Pathol; 2013 Sep; 183(3):681-91. PubMed ID: 23827819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers.
    Hardy CSC; Ghaedi H; Slotman A; Sjödahl G; Gooding RJ; Berman DM; Jackson CL
    J Histochem Cytochem; 2022 May; 70(5):357-375. PubMed ID: 35437049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
    Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
    J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer.
    Jackson CL; Chen L; Hardy CS; Ren KY; Visram K; Bratti VF; Johnstone J; Sjödahl G; Siemens DR; Gooding RJ; Berman DM
    J Pathol Clin Res; 2022 Mar; 8(2):143-154. PubMed ID: 34697907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological determinants of bladder cancer gene expression subtypes.
    Aine M; Eriksson P; Liedberg F; Sjödahl G; Höglund M
    Sci Rep; 2015 Jun; 5():10957. PubMed ID: 26051783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Update on molecular classifications and new histological classification of bladder cancer].
    Varinot J; Furudoï A; Roupret M; Compérat E
    Prog Urol; 2016; 26(11-12):600-607. PubMed ID: 27663304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy.
    Hesswani C; Jackson CL; Marcq G; Hardy C; Kool R; Mansure JJ; Brimo F; Berman DM; Kassouf W
    Eur Urol Open Sci; 2023 Nov; 57():22-29. PubMed ID: 38020525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
    Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A molecular taxonomy for urothelial carcinoma.
    Sjödahl G; Lauss M; Lövgren K; Chebil G; Gudjonsson S; Veerla S; Patschan O; Aine M; Fernö M; Ringnér M; Månsson W; Liedberg F; Lindgren D; Höglund M
    Clin Cancer Res; 2012 Jun; 18(12):3377-86. PubMed ID: 22553347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
    Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
    Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current status of molecular biomarkers in patients with metastatic urothelial carcinoma of the bladder.
    Kerr PS; Freedland SJ; Williams SB
    Expert Rev Mol Diagn; 2020 Feb; 20(2):127-129. PubMed ID: 31495246
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
    Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary tract tumors].
    Uchida K; Shiraishi T
    Rinsho Byori; 2014 Jun; 62(6):586-95. PubMed ID: 25151778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.
    Roychowdhury A; Dey RK; Bandyapadhyay A; Bhattacharya P; Mitra RB; Dutta R
    J Indian Med Assoc; 2012 Jun; 110(6):393-6. PubMed ID: 23360043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.